Table 1.
Relationship between Twist2 expression and clinicopathological characteristics n (%)
| Characteristics | Total | Twist2 expression | P value | |
| Negative | Positive | |||
| Gender | ||||
| Female | 52 (55.9) | 18 (66.7) | 34 (51.5) | 0.1821 |
| Male | 41 (44.1) | 9 (33.3) | 32 (48.5) | |
| Age | ||||
| < 59 | 41 (44.1) | 13 (48.1) | 28 (42.4) | 0.6141 |
| ≥ 59 | 52 (55.9) | 14 (51.9) | 38 (57.6) | |
| T-stage | ||||
| T1-2 | 17 (18.3) | 5 (18.5) | 12 (18.2) | 1.0002 |
| T3-4 | 76 (81.7) | 22 (81.5) | 54 (81.8) | |
| N-stage | ||||
| N0 | 52 (55.9) | 17 (63.0) | 35 (53.0) | 0.3811 |
| N1-2 | 41 (44.1) | 10 (37.0) | 31 (47.0) | |
| M-stage | ||||
| M0 | 52 (55.9) | 17 (63.0) | 35 (53.0) | 0.3811 |
| M1 | 41 (44.1) | 10 (37.0) | 31 (47.0) | |
| Tumor differentiation | ||||
| Moderate/good | 83 (89.2) | 26 (96.3) | 57 (86.4) | 0.2712 |
| Poor | 10 (10.8) | 1 (3.7) | 9 (13.6) | |
| Vascular invasion | ||||
| No | 56 (60.2) | 17 (63.0) | 39 (59.1) | 0.7291 |
| Yes | 37 (39.8) | 10 (37.0) | 27 (40.9) | |
| Tumor location | ||||
| Rectum | 19 (20.4) | 4 (14.8) | 15 (22.7) | 0.3901 |
| Colon | 74 (79.6) | 23 (85.2) | 51 (77.3) | |
| CEA level (ng/mL) | ||||
| ≤ 5 | 48 (51.6) | 12 (4.4) | 36 (54.5) | 0.3761 |
| > 5 | 45 (48.4) | 15 (55.6) | 30 (45.5) | |
1
Pearson’s χ2 test;
2
Fisher’s exact test. T-, N-, M-stage are tumor, node, and metastasis stage (6th edition), performed according to the American Joint Committee on Cancer; CEA: Serum carcinoembryonic antigen.